Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Skien – page 3

51 clinical trials in Skien, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Skien at a glance
51
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

51 trials in Skien

Open in trial search

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Merck Sharp & Dohme LLC

Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:St. Olavs Hospital HF

Obesity

Recruiting

Study on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Vestfold Hospital Trust

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Helse Bergen HF

Prostate cancer+1

Recruiting

Study on Atorvastatin's Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Pirkanmaan hyvinvointialue

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ispaghula husk
  • Sponsor:Sykehuset Telemark HF

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Region Skane

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Skien

What the registry says about research in the country

01 Autoimmune & Rheumatic Conditions

Innovative research focusing on rheumatic diseases and their complications, including studies of new treatments for lung fibrosis and improved monitoring methods for rheumatoid arthritis patients.

  • Systemic Autoimmune Rheumatic Diseases
  • Therapeutic Drug Monitoring
  • Interstitial Lung Disease Management

Studies aim to evaluate novel therapeutic approaches and disease monitoring strategies.

02 Oncology Research

Comprehensive cancer studies exploring precision medicine approaches, including targeted therapies for rare cancers and innovative treatment strategies for metastatic disease.

  • Advanced Malignancy Treatment
  • Prostate Cancer Management
  • Pain Management in Cancer

Research focuses on improving treatment outcomes through personalized therapeutic approaches.

03 Neurological & Sensory Disorders

Clinical investigations of Multiple Sclerosis treatments and innovative approaches for sudden hearing loss, including comparative studies of established therapies.

  • MS Treatment Optimization
  • Hyperbaric Oxygen Therapy
  • Auditory System Disorders

Studies evaluate both conventional and novel therapeutic interventions.

04 Other Medical Specialties

Diverse research including respiratory infections, surgical procedures, and specialized treatments for cardiovascular disease in dialysis patients.

  • Antibiotic Management
  • Surgical Wound Care
  • Addiction Medicine

Focus on improving patient outcomes across various medical conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.